Please Wait
Applying Filters...
menu
    • menu
    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Atenolol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 26Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    28/09/2024 Emcure Pharmaceuticals
    India
    		 Ankuk Pharmaceutical Co., Ltd. 20110414-125-H-59-01 Esatenolol 2011-04-14 Emcure Pharmaceuticals Ltd. India Plot No. D-24 & D-24/1, MIDC, Kurkumbh, Tal.: Daund, Pune-413 802, Maharashtra, India
    28/09/2024 Ipca Laboratories
    India
    		 Korea United Pharmaceutical Co., Ltd. 20050831-34-B-91-04(8) Atenolol 2011-06-30 IPCA Laboratories Limited India PO Sejavta Dist. Ratlam(MP)PIN. 457 002, India